Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 102,638 | 103,607 | 99,493 | 83,355 | 75,582 |
| Operating Income | -102,638 | -103,607 | -99,493 | -83,355 | -75,582 |
| Interest Expense | 1,217 | 1,213 | 1,289 | 1,459 | 314 |
| Other Income | 7,450 | 7,468 | -1,710 | 3,884 | 2,367 |
| Pre-tax Income | -96,405 | -97,352 | -102,492 | -80,930 | -73,529 |
| Net Income Continuous | -96,405 | -97,352 | -102,492 | -80,930 | -73,529 |
| Net Income | $-96,405 | $-97,352 | $-102,492 | $-80,930 | $-73,529 |
| EPS Basic Total Ops | -0.52 | -0.53 | -0.61 | -0.50 | -0.53 |
| EPS Basic Continuous Ops | -0.56 | -0.60 | -0.69 | -0.59 | -0.64 |
| EPS Diluted Total Ops | -0.52 | -0.53 | -0.61 | -0.50 | -0.53 |
| EPS Diluted Continuous Ops | -0.56 | -0.60 | -0.69 | -0.59 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.52 | -0.53 | -0.55 | -0.50 | -0.53 |
| EBITDA(a) | $-102,574 | $-103,883 | $-99,683 | $-82,581 | $-74,648 |